Skip to main content

Abstract

Heart valve centers of excellence include a specialist valve clinic and multidisciplinary teams delivering interventions. The valve clinic assesses new outpatients and monitors those with moderate and severe valve disease to determine the optimum timing of surgery. It also supervises inpatient care for valve disease including infective endocarditis. The minimum interventions offered are: replacement of valves in all 4 positions; mitral valve repair; tricuspid annuloplasty and repair; ancillary procedures, left atrial appendage closure, AF ablation; percutaneous balloon mitral valvotomy; TAVI; percutaneous repair of paraprosthetic regurgitation; aortic replacement. The core of the multidisciplinary teams is a cardiologist specialising in valve disease, an echocardiographer, an interventional cardiologist and a surgeon. There must be expert imaging including CMR and CT and a variety of cardiac and non-cardiac associated specialists including electrophysiologists, intensivists, spinal specialists and geneticists. This chapter discusses consensus views on standards for the components of the center of excellence including individual surgeon and center volumes. Good results are usually associated with high individual and center volumes, but this relationship is complex. Results of surgery should be published by center and should include rates of residual regurgitation rates for mitral repairs and reoperation rates matched to the preoperative pathology and risk. The center should be involved with methods of improving detection of valve disease in the community and national programmes of training and audit.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Lancellotti P, Rosenhek R, Pibarot P, Iung B, Otto CM, Tornos P, et al. Heart valve clinics: organisation, structure and experiences. Eur Heart J. 2013;34:1597–606.

    Article  Google Scholar 

  2. Chambers J, Sandoe J, Ray S, Prendergast B, Taggart D, Westaby S, et al. The infective endocarditis team: recommendations from an international working group. Heart. 2014;100:524–7.

    Article  Google Scholar 

  3. Arden C, Chambers J, Ray S, Prendergast B, Taggart D, Westaby S, Grothier L, Wilson J, Campbell B, Sandoe J, Gohlke-Bärwolf C, Mestres C, Rosenhek R, Pibarot P, Otto C. Can we improve the detection of heart valve disease? Heart. 2014;100:271–3.

    Article  Google Scholar 

  4. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, et al. AHA/ACC Guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 2014. https://doi.org/10.1016/j.jacc.2014.02.536.

    Article  Google Scholar 

  5. Chambers J, Ray S, Prendergast B, Graham T, Campbell B, Greenhalgh D, Petrou M, Tinkler J, Gohlke-Bärwolf C, Mestres C, Rosenhek R, Pibarot P, Otto C, Sundt T. Standards for heart valve surgery in a ‘Heart Valve Centre of Excellence’. Open Heart. 2015b;2(1):e000216.

    Article  Google Scholar 

  6. Chambers J, Prendergast B, Iung B, Rosenhe R, Zamoran JL, Piérard LA, Modine T, Falk V, Kappetein AP, Pibarot P, Sundt T, Baumgartner H, Bax JJ, Lancellotti P. Standards defining a “Heart Valve Centre”: ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint. Euro Heart J. 2017;38:2177–83; and Eur J Cardiothorac Surg 2017;52:418–24

    Article  Google Scholar 

  7. Fink JC, Schmid CH, Selker HP. A decision aid for referring patients with systolic murmurs for echocardiography. J Gen Int Med. 1994;9:479–84.

    Article  CAS  Google Scholar 

  8. Mangione S, Nieman LZ. Cardiac auscultatory skills of internal medicine and family practice trainees. A comparison of diagnostic proficiency. JAMA. 1997;278:717–22.

    Article  CAS  Google Scholar 

  9. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, Tornos P, Vanoverschelde J-L, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on valvular heart disease. Eur Heart J. 2003;24:1231–43.

    Article  Google Scholar 

  10. Taggu W, Topham A, Hart L, Carr-White G, Sulke N, Patel NR, Lloyd G. A cardiac sonographer led follow up clinic for heart valve disease. Int J Cardiol. 2009;132:240–3.

    Article  Google Scholar 

  11. Iung B. Management of the elderly patient with aortic stenosis. Heart. 2008;94:519–24.

    Article  Google Scholar 

  12. Savage EB, Ferguson TB, DeSesa VJ. Use of mitral valve repair: analysis of contemporary United States experience reported by the society of thoracic surgeons national cardiac database. Ann Thorac Surg. 2003;75:820–5.

    Article  Google Scholar 

  13. Nihoyannopoulos P, Fox K, Fraser A, Pinto F. EAE laboratory standards and accreditation. Eur J Echo. 2007;8:80–7.

    Article  CAS  Google Scholar 

  14. Picard MH, Adams D, Bierig SM, et al. American Society of Echocardiography recommendations for quality echocardiography laboratory operations. J Am Soc Echo. 2011;24(1):1–10. https://doi.org/10.1016/j.echo.2010.11.006.

    Article  Google Scholar 

  15. Van Dyck MJ, Watremez C, Boodwhani M, Vanoverschelde J-L, El Khoury G. Transesophageal echocardiographic evaluation during aortic valve repair surgery. Anesth Analg. 2010;111:59–70.

    Article  Google Scholar 

  16. McCarthy PM. When is your surgeon good enough? When do you need a ‘referent surgeon’? Curr Cardiol Rep. 2009;11:107–13.

    Article  Google Scholar 

  17. Vincent C, Moorthy K, Sarker SK, Chang A, Darzi AW. Systems approaches to surgical quality and safety. From concept to measurement. Ann Surg. 2004;239:475–82.

    Article  Google Scholar 

  18. Bridgewater B, Hooper T, Munsch C, et al. Mitral repair best practice: proposed standards. Heart. 2006;92:939–44.

    Article  CAS  Google Scholar 

  19. Fedak PW, McCarthy PM, Bonow RO. Evolving concepts and technologies in mitral valve repair. Circulation. 2008;117:963–74.

    Article  Google Scholar 

  20. David TE, Ivanov J, Armstrong S. Late outcomes of mitral valve repair for floppy valves: implications for asymptomatic patients. J Thorac Cardiovasc Surg. 2003;125:1143–52.

    Article  Google Scholar 

  21. Braunberger E, Deloche A, Berrebi F, Abdallah F, Celestin JA, Meimoun P, Chatellier G, Chavaud S, Fabiani JN, Carpentier A. Very long-term results (more than 20 years) of valve repair with Carpentier’s techniques with non rheumatic mitral valve insufficiency. Circulation. 2001;104(12 Suppl 1):I8–11.

    Article  CAS  Google Scholar 

  22. Tomasso CL, Bolman RM, Feldman T, et al. Multisociety (AATS, ACCF, SCAI, and STS) expert consensus statement: operator and institutional requirements for transcatheter valve repair and replacement, part 1: transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;59:2028–42.

    Article  Google Scholar 

  23. Tommaso CL, Fullerton DA, Feldman T, et al. SCAI/AATS/ACC/STS operator and institutional requirements for transcatheter valve repair and replacement. Part II mitral valve. J Am Coll Cardiol. 2014;64:1515–26.

    Article  Google Scholar 

  24. Ionescu A, McKenzie C, Chambers J. Are valve clinics a sound investment for the health service? A cost-effectiveness model and an automated tool for cost estimation. Open Heart. 2015;2:e000275. https://doi.org/10.1136/openhrt-2015-000275.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Parkin D, Chambers J. Routine follow-up for patients with prosthetic valves: the value of a nurse-led valve clinic. Br J Cardiol. 2012;19:204–6.

    Article  Google Scholar 

  26. Parkin D, Chambers J. What is the value of a nurse-led clinic for patients with replacement heart valves? Br J Cardiac Nurs. 2015;10:145–9.

    Article  Google Scholar 

  27. Chambers JB, Lloyd G, Rimington HM, Parkin D, Hates AM, Baldrock-Apps G, Topham A. Multidisciplinary valve clinics with devolved surveillance: a 2 year audit. Br J Cardiol. 2011;18:231–2.

    Article  Google Scholar 

  28. Bhattacharyya S, Pavitt C, Lloyd G, Chambers JB. Provision, organisation and models of heart valve clinics within the United Kingdom. Q J Med. 2015;108:113–7. https://doi.org/10.1093/qjmed/hcu164. First published online: 6 Aug 2014.

    Article  CAS  Google Scholar 

  29. Bruun NE, Habib G, Thuny F, Sogaard P. Cardiac imaging in infectious endocarditis. Eur Heart J. 2014;35:624–32.

    Article  Google Scholar 

  30. Holzhey DM, Seeburger J, Misfeld M, Borger MA, Mohr FW. Learning minimally-invasive mitral valve surgery: a cumulative sum sequential probability analysis of 3895 operations from a single high volume center. Circulation. 2013;128:483–91.

    Article  Google Scholar 

  31. Kilic A, Shah AS, Conte JV, Baumgartner WA, Yuh DD. Operative outcomes in mitral valve surgery: combined effects of surgeon and hospital volume in a population-based analysis. J Thorac Cardiovasc Surg. 2013;146:638–46.

    Article  Google Scholar 

  32. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology foundation/American Heart Association task force on practice guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574–651.

    PubMed  Google Scholar 

  33. Karthikesingam A, Hinchcliffe RJ, Loftus IM, Thompson MM, Holt PJ. Volume-outcome relationships in vascular surgery: the current status. J Endovasc Ther. 2010;17:356–65.

    Article  Google Scholar 

  34. Bolling SF, Li S, O’Brien SM, Brennan JM, Prager RL, Gammie JS. Predictors of mitral valve repair: clinical and surgeon factors. Ann Thorac Surg. 2010;90:1904–11.

    Article  Google Scholar 

  35. Gammie JS, O’Brien SM, Griffith BP, Ferguson TB, Peterson ED. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation. 2007;115:881–7.

    Article  Google Scholar 

  36. Birkmeyer JD, Siewers AE, Finlayson EVA, Stukel TA, Lucas FL, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128–37.

    Article  Google Scholar 

  37. Vassileva CM, Boley T, Markwell S, Hazelrigg S. Impact of hospital annual mitral procedural volume on mitral valve repair rates and mortality. J Heart Valve Dis. 2012;21:41–7.

    PubMed  Google Scholar 

  38. Rahimtoola SH. Choice of prosthetic heart valve in adults. J Am Coll Cardiol. 2010;55:2413–26.

    Article  Google Scholar 

  39. Unger P, Dedobbeleer C, van Camp G, Plein D, Cosyns B, Lancellotti P. Mitral regurgitation in patients with aortic stenosis undergoing valve replacement. Heart. 2010;96:9–14.

    Article  CAS  Google Scholar 

  40. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33:2451–96.

    Article  Google Scholar 

  41. Aicher D, Fries R, Rodionycheva S, Schmidt K, Langer F, Schaefers HJ. Aortic valve repair leads to a low incidence of valve-related complications. Eur J Cardiothorac Surg. 2010;37:127–32.

    Article  Google Scholar 

  42. Langer F, Aicher D, Kissinger A, Wendler O, Lausberg H, Fries R, Schaefers H-J. Aortic valve repair using a differentiated surgical strategy. Circulation. 2004;110(Suppl II):II-67–73.

    Google Scholar 

  43. le Polain de Waroux JB, Pouleur AC, Robert A, Pasquet A, Gerber BL, Noirhomme P, El Khoury G, Vanoverschelde JL. Mechanisms of recurrent aortic regurgitation after aortic valve repair. J Am Coll Cardiol Cardiovasc Imaging. 2009;2:931–9.

    Article  Google Scholar 

  44. Botelho-Nevers E, Thuny F, Casalta JP, et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med. 2009;169:1290–8.

    Article  Google Scholar 

  45. Tornos P, Iung B, Permanyer-Miralda G, Baron G, Delahaye F, Gohlke-Bärwolf C, Butchart EG, Ravaud P, Vahanian A. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart. 2005;91(5):571.

    Article  CAS  Google Scholar 

  46. Ruttmann E, Hangler HB, Kilo J, Hṏfer D, Műller LC, Hintringer F, Műller S, Laufer G, Antretter H. Transvenous pacemaker lead removal is safe and effective even in large vegetations: an analysis of 53 cases of pacemaker lead endocarditis. Pacing Clin Electrophysiol. 2006;29:231–6.

    Article  Google Scholar 

  47. Thuny F, Beurtheret S, Mancini J, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated endocarditis: a propensity analysis. Eur Heart J. 2011;32:2027–33.

    Article  Google Scholar 

  48. Iung B, Rousseau-Paziaud J, Cormier B, Garbarz E, Fondard O, Brochet E, Acar C, Couëtil J-P, Hvass U, Vahanian A. Contemporary results of mitral valve repair for infective endocarditis. J Am Coll Cardiol. 2004;43:386–92.

    Article  Google Scholar 

  49. d’Arcy JL, Coffey S, Loudon M, Kennedy A, Pearson-Stuttard J, Birks J, Frangou E, Farmer AJ, Mant D, Wilson J, Myerson SG, Prendergast BD. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: The OxVALVE Population Cohort Study. Eur Heart J. 2016;37(47):3515–22. https://doi.org/10.1093/eurheartj/ehw229.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Roldan CA, Shively BK, Crawford MH. Value of cardiovascular physical examination for detecting valvular heart disease in asymptomatic subjects. Am J Cardiol. 1996;77:1327–31.

    Article  CAS  Google Scholar 

  51. Marijon E, Ou P, Celermajer S, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357:470–6.

    Article  CAS  Google Scholar 

  52. McDonald, Daly, Jelinek, et al. Opening Pandora’s box: the unpredictability of reassurance by a normal test result. Br Med J. 1996;313:329–32.

    Article  CAS  Google Scholar 

  53. Stoate HG. Can health screening damage your health? JR Coll Gen Pract. 1989;39:193–5.

    CAS  Google Scholar 

  54. Douglas PS, Garcia MJ, Haines DE, et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011. Appropriate use criteria for echocardiography. JACC. 2011;57:1126–66.

    Article  Google Scholar 

  55. Chambers JB, Kabir S, Cajeat E. The detection of heart disease by open access echocardiography: a retrospective analysis. Br J Gen Pract. 2014;64:86–7.

    Article  Google Scholar 

  56. McBride KL, Garg V. Heredity of bicuspid aortic valve: is family screening indicated? Heart. 2011;97:1193–5.

    Article  Google Scholar 

  57. Warnes CA, Williams RG, Bashore TM, et al. 2008 guidelines for the management of adults with congenital heart disease. JACC. 2008;52:e1–e121.

    Article  Google Scholar 

  58. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685–94.

    Article  Google Scholar 

  59. Eveborn GW, Schirmer H, Heggelund G, et al. The evolving epidemiology of valvular aortic stenosis. The Tromso Study. Heart. 2012;99(6):396–400. https://doi.org/10.1136/heartjnl-2012-302265.

    Article  PubMed  Google Scholar 

  60. Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220–5.

    Article  CAS  Google Scholar 

  61. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. JACC. 1997;29:630–4.

    Article  CAS  Google Scholar 

  62. Grant SW, Devbhandari MP, Grayson AD, et al. What is the impact of providing a Transcatheter Aortic Valve Implantation (TAVI) service on conventional aortic valve surgical activity, patient risk factors and outcomes in the first two years? Heart. 2012;96:1633–7.

    Article  Google Scholar 

  63. Grant SW, Hickey GL, Cosgriff R, Cooper G, Deanfield J, Roxburgh J, Bridgewater B. Creating transparency in UK adult cardiac surgery data. Heart. 2013;99:1067–8.

    Article  Google Scholar 

  64. Wijns W, Kolh PH. Experience with revascularization procedures does matter: low volume means worse outcome. Eur Heart J. 2010;31(16):1954–7. https://doi.org/10.1093/eurheart/ehq172.

    Article  PubMed  Google Scholar 

  65. Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation. 2006;113:2238–44.

    Article  Google Scholar 

  66. Zilbersak R, Gabriel H, Maurer G, Rosenhek R. Optimized timing of surgery in aortic stenosis: impact of a valve clinic program

    Google Scholar 

  67. Gurzun MM, Ionescu A. Appropriateness of use criteria for transthoracic echocardiography: are they relevant outside the USA? Eur Heart J Cardiovasc Imaging. 2014;15:450–5.

    Article  Google Scholar 

  68. Zaidi A, Ionescu A, Sharma R, et al. Echocardiographic surveillance of aortic valve stenosis: towards a standardized approach. J Heart Valve Dis. 2012;21:707–13.

    PubMed  Google Scholar 

  69. Turpie D, Maycock M, Crawford C, et al. Establishing an aortic surveillance clinic. Br J Cardiol. 2010;17(6):286–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John B. Chambers M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Cite this chapter

Chambers, J.B., Lancellotti, P. (2018). The Heart Valve Centre. In: Fattouch, K., Lancellotti, P., Vannan, M., Speziale, G. (eds) Advances in Treatments for Aortic Valve and Root Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-66483-5_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-66483-5_27

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-66482-8

  • Online ISBN: 978-3-319-66483-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics